1-6 of 6
Martin H. Dreyling, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prolonged Remission Duration with Interferon Maintenance After Rituximab-Containing Induction in First-Line Advanced Stage Lymphoplasmacytic Lymphoma – a Retrospective Analysis of the German Low-Grade Lymphoma Study Group (GLSG)

Eva Hoster, Dr., Michael Unterhalt, Dr., Bernd Metzner, Michael Pfreundschuh, MD, Peter Staib, Georg Jacobs, Hans Walter Lindemann, Wolf-Dieter Ludwig, H. Tilman Steinmetz, Lorenz Truemper, Hannes Wandt, Christian Buske, Martin H. Dreyling, PhD, Wolfgang Hiddemann, PhD
Journal: Blood
Blood (2011) 118 (21): 1639.
https://doi.org/10.1182/blood.V118.21.1639.1639
Published: 2011
Journal Articles

Differential Role of the B-Cell Receptor Pathway in Diffuse Large Cell B Cell Lymphoma: Temsirolimus Has Additive Effects in Combination with the BTK Inhibitor PCI-32765 and PI3K Inhibitor Cal101 but Antagonizes Bortezomib in GCB Subtype

Anna-Katharina Zoellner, Stephan Bayerl, Marc Weinkauf, Georg Hess, Wolfgang Hiddemann, MD, Martin H. Dreyling, PhD
Journal: Blood
Blood (2011) 118 (21): 1664.
https://doi.org/10.1182/blood.V118.21.1664.1664
Published: 2011
Journal Articles

Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group

Petra Jenke, Barbara Eichhorst, MD, Raymonde Busch, Nadine Anheier, Ulrich Duehrsen, MD, Jan Duerig, Martin H. Dreyling, PhD, Manuela Bergmann, MD, Maria Elisabeth Goebeler, Hans Juergen Hurtz, Martina Beate Stauch, Stephan Stilgenbauer, MD, Hartmut Doehner, Prof. Dr. med., Anna-Maria Fink, MD, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Michael Hallek, MD
Journal: Blood
Blood (2011) 118 (21): 2860.
https://doi.org/10.1182/blood.V118.21.2860.2860
Published: 2011
Journal Articles

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial

Georg Hess, MD, Ulrich Keller, MD, Johannes Atta, Christian Buske, Peter Borchmann, MD, Christoph Medler, Mathias Witzens-Harig, Martin H. Dreyling, PhD
Journal: Blood
Blood (2011) 118 (21): 2697.
https://doi.org/10.1182/blood.V118.21.2697.2697
Published: 2011
Journal Articles

Role of Microenvironment-Associated Chemokines and Cytokines for Binet Stage A CLL Patients Included in a Prospective Trial (CLL1 trial) of the German CLL Study Group (GCLLSG): sIl2Ralpha Is An Independent Predictor of Progression-Free Survival (PFS),

Till M Seiler, MD, Roland Aydin, Tobias Herold, MD, Raymonde Busch, Markus Schwarz, MD, Stefan Holdenrieder, MD, Barbara Eichhorst, MD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD, Michael Hallek, MD, Martin H. Dreyling, PhD, Manuela A. Bergmann, MD
Journal: Blood
Blood (2011) 118 (21): 3869.
https://doi.org/10.1182/blood.V118.21.3869.3869
Published: 2011
Journal Articles

High Expression of the Endoplasmic Reticulum Protein MZB1 predicts Inferior Prognosis in Chronic Lymphocytic Leukemia, Follicular Lymphoma and Diffuse Large B-Cell Lymphoma and Is Associated with a Unique Gene Expression Profile,

Tobias Herold, MD, Medhanie A Mulaw, PhD, Vindi Jurinovic, Till M Seiler, MD, Klaus H. Metzeler, MD, Annika Dufour, PhD, Stephanie Schneider, PhD, Purvi Kakadia, PhD, Karsten Spiekermann, MD, Ulrich Mansmann, Wolfgang Hiddemann, MD, Christian Buske, Martin H. Dreyling, PhD, Stefan K Bohlander, MD
Journal: Blood
Blood (2011) 118 (21): 3657.
https://doi.org/10.1182/blood.V118.21.3657.3657
Published: 2011